American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$374M |
| 2 |
Meta Platforms (Facebook)
META
|
+$255M |
| 3 |
Salesforce
CRM
|
+$200M |
| 4 |
Target
TGT
|
+$132M |
| 5 |
Reinsurance Group of America
RGA
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$322M |
| 2 |
Visa
V
|
+$240M |
| 3 |
T-Mobile US
TMUS
|
+$229M |
| 4 |
MSCI
MSCI
|
+$209M |
| 5 |
IQVIA
IQV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
2351
DELISTED
Verve Therapeutics
VERV
| $340K | ﹤0.01% |
+18,150
| New | +$302K |
|
|
AGR
2352
DELISTED
Avangrid, Inc.
AGR
| $339K | ﹤0.01% |
9,002
-66,029
| -88% | -$2.59M |
|
2353
DigitalOcean
DOCN
$15.7B
| $338K | ﹤0.01% |
8,431
+79
| +0.9% | +$2.91K |
|
2354
TETRA Technologies
TTI
$1.29B
| $337K | ﹤0.01% |
99,697
+19,394
| +24% | +$56.1K |
|
2355
ACM Research
ACMR
$5.66B
| $334K | ﹤0.01% |
+25,544
| New | +$269K |
|
2356
nLIGHT
LASR
$3.06B
| $329K | ﹤0.01% |
+21,340
| New | +$261K |
|
2357
Orthofix Medical
OFIX
$424M
| $328K | ﹤0.01% |
+18,165
| New | +$339K |
|
2358
Janus International
JBI
$664M
| $327K | ﹤0.01% |
30,678
+19,378
| +171% | +$181K |
|
|
EQRX
2359
DELISTED
EQRx, Inc. Common Stock
EQRX
| $326K | ﹤0.01% |
175,464
+63,543
| +57% | +$114K |
|
2360
Theravance Biopharma
TBPH
$878M
| $326K | ﹤0.01% |
31,482
+10,278
| +48% | +$113K |
|
2361
Graham Corp
GHM
$1.33B
| $325K | ﹤0.01% |
24,451
+971
| +4% | +$12.2K |
|
2362
Rush Enterprises Class B
RUSHB
$9.18B
| $324K | ﹤0.01% |
7,149
+63
| +0.9% | +$2.55K |
|
|
XOMA
2363
DELISTED
Xoma
XOMA
| $322K | ﹤0.01% |
17,071
-10,966
| -39% | -$206K |
|
2364
HealthStream
HSTM
$829M
| $321K | ﹤0.01% |
+13,054
| New | +$324K |
|
2365
Vicor
VICR
$10.4B
| $320K | ﹤0.01% |
5,922
-1,968
| -25% | -$97.1K |
|
2366
Unity
U
$19.6B
| $320K | ﹤0.01% |
7,364
+487
| +7% | +$15.6K |
|
2367
Avis
CAR
$4.93B
| $316K | ﹤0.01% |
1,382
| – | – |
|
2368
LivaNova
LIVN
$4.45B
| $315K | ﹤0.01% |
+6,121
| New | +$287K |
|
|
CVGW
2369
DELISTED
Calavo Growers
CVGW
| $315K | ﹤0.01% |
+10,842
| New | +$336K |
|
2370
Sotera Health
SHC
$5.39B
| $313K | ﹤0.01% |
16,593
+3,691
| +29% | +$58.7K |
|
2371
uniQure
QURE
$3.13B
| $312K | ﹤0.01% |
27,266
+9,315
| +52% | +$176K |
|
|
NXGN
2372
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $312K | ﹤0.01% |
+19,250
| New | +$319K |
|
2373
ARS Pharmaceuticals
SPRY
$601M
| $311K | ﹤0.01% |
46,368
+7,236
| +18% | +$48.3K |
|
2374
Columbia Financial
CLBK
$1.21B
| $310K | ﹤0.01% |
17,922
+3,863
| +27% | +$67K |
|
2375
Morningstar
MORN
$7.41B
| $308K | ﹤0.01% |
1,570
+7
| +0.4% | +$1.39K |
|
Similar funds
American Century Companies's Q2 2023 Portfolio in Review
As of Q2 2023, American Century Companies held 2,884 positions worth $133B, up 4.5% from $127B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q2 2023 filing shows 216 new, 1,601 increased, 807 reduced and 96 closed positions. Its largest new stake was Kenvue: 2,518,495 shares worth $66.5M. The largest sale was Microsoft, an estimated $322M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q2 2023 buy was Kenvue: 2,518,495 shares worth $66.5M.
- American Century Companies added most to Becton Dickinson in Q2 2023, an estimated $374M increase.
- American Century Companies's biggest Q2 2023 reduction was Microsoft, cutting an estimated $322M.
- American Century Companies fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $199M.
- American Century Companies's ten largest holdings make up 22% of its $133B portfolio in Q2 2023.
- American Century Companies opened 216 new positions and closed 96 in Q2 2023.
- American Century Companies's portfolio value rose 4.5% quarter-over-quarter to $133B.
Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.